(Q42145532)

17 October 2017

title

MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma (English)

1 reference

17 October 2017

5

Xian-Cheng Zeng

1 reference

17 October 2017

De-Hao Huang

1

1 reference

17 October 2017

Guo-Ying Wang

2

1 reference

17 October 2017

Jian-Wen Zhang

3

1 reference

17 October 2017

Yang Li

4

1 reference

17 October 2017

Nan Jiang

6

1 reference

17 October 2017

publication date

27 April 2015

1 reference

Japanese Journal of Clinical Oncology

17 October 2017

published in

1 reference

17 October 2017

volume

45

1 reference

17 October 2017

issue

8

1 reference

17 October 2017

page(s)

738-744

1 reference

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

CYLD regulates keratinocyte differentiation and skin cancer progression in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Reduced expression of CYLD in human colon and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Clinical significance of CYLD downregulation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Identification of novel genes coding for small expressed RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNA silencing in primates: towards development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNA-501 promotes HBV replication by targeting HBXIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

CYLD: a deubiquitination enzyme with multiple roles in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV063

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYV063

1 reference

17 October 2017

1 reference